Idorsia (Switzerland) Insiders
| IDIA Stock | CHF 0.80 0.04 5.26% |
Idorsia employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Idorsia's management performance can provide insight into the venture performance.
| Simon Jose Insider Ex Officer |
| Andrew Weiss Insider Sr Communications |
Idorsia |
Idorsia Management Team Effectiveness
The company has return on total asset (ROA) of (0.4196) % which means that it has lost $0.4196 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (64.6068) %, meaning that it generated substantial loss on money invested by shareholders. Idorsia's management efficiency ratios could be used to measure how well Idorsia manages its routine affairs as well as how well it operates its assets and liabilities.Idorsia Workforce Comparison
Idorsia is rated fourth overall in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 13,017. Idorsia adds roughly 11.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Idorsia Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Idorsia Price Series Summation is a cross summation of Idorsia price series and its benchmark/peer.
Idorsia Notable Stakeholders
An Idorsia stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Idorsia often face trade-offs trying to please all of them. Idorsia's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Idorsia's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Simon Jose | Ex Officer | Profile | |
| Andrew Weiss | Sr Communications | Profile | |
| Olivier Lambert | Sr Assurance | Profile | |
| Christoph Boss | VP Chemistry | Profile | |
| Martine Clozel | Ex Officer | Profile | |
| JeanPaul MD | CEO Director | Profile | |
| Alexander Khatuntsev | VP HR | Profile | |
| Andr Muller | Ex CFO | Profile | |
| Julien LLM | Group VP | Profile | |
| Guy MD | Ex Officer | Profile | |
| Markus Riederer | VP Biology | Profile |
About Idorsia Management Performance
The success or failure of an entity such as Idorsia often depends on how effective the management is. Idorsia management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Idorsia management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Idorsia management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland. Idorsia Ltd is traded on Switzerland Exchange in Switzerland.
Please note, the imprecision that can be found in Idorsia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Idorsia. Check Idorsia's Beneish M Score to see the likelihood of Idorsia's management manipulating its earnings.
Idorsia Workforce Analysis
Traditionally, organizations such as Idorsia use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Idorsia within its industry.Idorsia Manpower Efficiency
Return on Idorsia Manpower
| Revenue Per Employee | 8.8M | |
| Revenue Per Executive | 8.8M | |
| Net Loss Per Employee | 75.3M | |
| Net Loss Per Executive | 75.3M |
Additional Tools for Idorsia Stock Analysis
When running Idorsia's price analysis, check to measure Idorsia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idorsia is operating at the current time. Most of Idorsia's value examination focuses on studying past and present price action to predict the probability of Idorsia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idorsia's price. Additionally, you may evaluate how the addition of Idorsia to your portfolios can decrease your overall portfolio volatility.